Opportunity timeline

PostedAug 14, 2026
DeadlineOct 1, 2026

In plain English

Los Alamos National Laboratory is offering licensing opportunities for MultiScan-AR, a mass-spectrometry method that identifies microbes and detects antibiotic resistance. The technology works with existing benchtop and portable instruments and is intended for clinical diagnostics, public health, field medicine, analytical platforms, and antimicrobial research. It is at technology readiness level 3, with U.S. Patent pending under LA-UR-26-27335; this is not a request for outside development services.

About this opportunity

MultiScan-AR from Los Alamos National Laboratory turns a routine mass spectrometry run into a high-resolution portrait of a microbe and its defenses, giving care teams the identity of a pathogen and its antibiotic-resistance profile in minutes to hours rather than the better part of a day. The method works with instruments that clinics and field laboratories already operate, from benchtop analyzers to portable units, so its advanced scanning technique and analysis pipeline add new diagnostic power without demanding an entirely new hardware footprint. For any organization racing to slow the spread of drug-resistant infections, the payoff is faster, more confident treatment decisions and a…

Time remaining

Closes Oct 1, 2026

17Days
:
14Hours
:
43Min
:
28Sec

Related Opportunities

Bid details are gathered and summarized automatically. Please verify details at the original source.

Ref No.

BS-63009D